Concerning pharmaceutical drug cost and utilization transparency.
3 documents for 2363 (2015-16)
|
|
Links | Document | Document Type | Description | Date |
|---|---|---|---|---|---|
|
|
(WORD) (HTM) (PDF) | House Bill 2363 | Bills | Original Bill | 1/8/2016 |
|
|
(WORD) (HTM) (PDF) | Digest of House Bill 2363 | Digests | Bill Digest | 1/11/2016 |
|
|
(WORD) (HTM) (PDF) | Initial House Analysis of House Bill 2363 | Bill Reports | Initial House Analysis 01-19-16 | 1/19/2016 |
Total Count: 3